Shreya Shukla
About Shreya Shukla
Shreya Shukla is the Director of Research and Co-Founder at Notch Therapeutics, where she has worked since 2020. She has a Ph.D. in Biomedical Engineering from the University of Toronto and has held various research positions, including at the University of Toronto and Georgia Institute of Technology.
Work at Notch Therapeutics
Shreya Shukla serves as the Director of Research and Co-Founder at Notch Therapeutics, a position she has held since 2020. In this role, she collaborates with senior leadership to coordinate the ideation phase and planning of new programs and technologies within the Notch pipeline. Shukla is actively involved in the development of Notch's proprietary 'Engineered Thymic Niche' technology. Additionally, she contributes to the company's intellectual property strategy and patent filings related to novel platform developments.
Education and Expertise
Shreya Shukla holds a Ph.D. in Biomedical Engineering from the University of Toronto, where she studied from 2008 to 2016. She also earned a Bachelor of Science in Biomedical Engineering from the Georgia Institute of Technology. Her educational background provides a strong foundation for her research and development work in the biotechnology sector.
Background
Before co-founding Notch Therapeutics, Shreya Shukla gained extensive experience in academia and industry. She worked as a Postdoctoral Fellow in the Zandstra laboratory at the University of Toronto for three months in 2017. Prior to that, she spent five years as a Research Technologist at the Georgia Institute of Technology from 2003 to 2008. She also held a position as a Scientist at Calimmune, Inc. for five months in 2016.
Achievements
Shreya Shukla has made significant contributions to the field of biomedical engineering, including a novel discovery involving the cell-surface molecule VCAM-1 to enhance Notch signaling. Her work has implications for the development of new therapeutic strategies. Additionally, she has played a key role in shaping the intellectual property strategy at Notch Therapeutics, contributing to patent filings related to innovative platform developments.